Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2 alpha Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer

Date
2013
Author
Akisik, Ebru Esin
Saip, Pinar
Topuz, Erkan
Igci, Abdullah
Ozmen, Vahit
Muslumanoglu, Mahmut
Eralp, Yesim
Keskin, Serkan
Akisik, Elif
Dalay, Nejat
Tunaci, Mehtap
Yilmaz, Sabri
Camlica, Hakan
Tuzlali, Sitki
Metadata
Show full item record
Abstract
Introduction: The primary aim of this study is to investigate the effect of change in the expression levels of survivin, glutathione-S-transferase P1 (GSTP1), and topoisomerase 2 alpha (TOP2A) on the response to antracyclin-based and taxane-based neoadjuvant chemotherapy.
URI
http://hdl.handle.net/20.500.12627/88866
https://doi.org/10.1097/coc.0b013e318243913f
Collections